直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Congress Passes the Coronavirus Stimulus Bill

April 1, 2020

Last week, Congress passed the Coronavirus Stimulus Bill. The Bill gives the USPTO the authority to “toll, waive, adjust, or modify, any timing deadline” as appropriate if the President’s declaration of emergency in response to the coronavirus pandemic “materially affects the functioning of the Patent and Trademark Office,” “prejudices the rights of applicants, registrants, patent owners, or others appearing before the Office,” or prevents users from filing a document or paying a fee timely. See Section 12004. The USPTO will issue a public notice if they “toll, waive, adjust, or modify, any timing deadline.”

Tags

COVID-19

Related Offices

Washington, DC

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Seminar

Global Patent Strategies for Life Sciences and Chemical Innovations: Key Developments in Europe and the United States – Osaka

December 10, 2026

Osaka

Seminar

Global Patent Strategies for Life Sciences and Chemical Innovations: Key Developments in Europe and the United States – Tokyo

December 8, 2026

Tokyo

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Seminar

The Augmented Practice 2026: Balancing AI Opportunity, Governance, and Risk

November 5, 2026

San Francisco

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Webinar

2026 Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches

October 14, 2026

Webinar

Articles

Who Is a “Consumer?” The Supreme Court Takes Up the Video Privacy Protection Act

October 12, 2026

Conference

2026 AIPPI World Congress

October 7-10, 2026

Hamburg

Articles

California Court Considers CIPA’s Application to Online Tracking as New Law Limits Private Actions

October 7, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP